TransMedics Group

TMDX - TransMedics GroupFinancials

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2017
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
242
-21
-
L
L
137
L
111
L
-33
-179
400
-212
0
0
-
-
12/2024
442
57
-
8%
1
229
16%
173
3
16
-129
23
-114
0
0
-
-
12/2025
605
136
-
31%
4.7
473
40%
14
0.1
156
-59
17
97
-0
0
-
-